4,6-Dichloro-2-[(1E)-2-phenylethenyl]pyrimidine, 98%, 1g

4-Tritylphenol, 95.0%, 5g

(3-METHYLISOXAZOL-4-YL)METHANAMINE HCL, 95.0%, 1g

5-(2-Cyclohexenyl)pyrimidine, 97.0%, 2g

4-Hydroxy-3-methoxycinnamic acid, 98.0%, 1kg

8-Fluoro-4-hydroxy-quinoline-3-carboxylic acid, 95.0%, 10g

Bispyrazolone, 97.0%, 5g

1-(4-Bromo-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, = 98.5% (HPLC), 10g

(S)-4-(1-(tert-butoxycarbonyl)ethyl)benzoic acid, 98%, 5g

3-(FLUOROMETHYL)-3-HYDROXYPYRROLIDINE HCL, 95.0%, 1g

2,7-Dibromonaphthalene, 95.0%, 100g

E-Plan phase EPLPHi 20x/0.40 infinity corrected IOS objective. Working distance 2.61 mm

2,3-Dichlorobenzenesulfonamide, 97.0%, 1g